Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a maintenance or deployment change rather than a modification to the study record.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Ewing sarcoma and Malignant fibrous histiocytoma to the page's conditions/keywords.SummaryDifference0.1%

- Check53 days agoChange DetectedAngiosarcoma was added as a MeSH term and a 2026 publication (IMMUNOSARC II Master Trial) was added to Publications; the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page footer. No changes to core study content or user-visible functionality.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page footer shows Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.